Rivaroxaban
- Product NDC
- 67877-882
- 11-digit product format
- 678770882
- Labeler code
- 67877
- Product ID
- 67877-882_d111f8d6-a073-4a43-bf16-bc1bacba9898
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rivaroxaban
- Dosage form
- GRANULE, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Ascend Laboratories, LLC
- Application
- ANDA218502
- Marketing category
- ANDA
- Marketing start
- 2025-07-07
- Substance
- RIVAROXABAN
- Active strength
- 155 mg/1
- Pharmacologic classes
- Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rivaroxaban
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIVAROXABAN | 155 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9NDF7JZ4M3 |
| Rxcui | 2588062 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67877-882-71 | Rivaroxaban | 1 in 1 BOTTLE | GRANULE, FOR SUSPENSION | 1 | | 5 |
| 67877-882-71 | Rivaroxaban | 1 in 1 CARTON | GRANULE, FOR SUSPENSION | 1 | | 5 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 67877-882-71 | 67877088271 | 1 BOTTLE in 1 CARTON (67877-882-71) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE | 1 bottle | 2025-07-07 | No | No | Historical |